Sign in

CIK 0001023024

  • Large accelerated filer

ANI PHARMACEUTICALS INC

Sign in to watch
Ticker
ANIP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
582301143
Phone
+1 609-759-1810
Business address
104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
Former names
BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,359,736
in 11 filings, $2.4M under 10b5-1 plans

Net −$2,359,736. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-04-16 PRZYBYL ARTHUR President and CEO Shares withheld for taxes −1,611 $60.21 $97K 208,631
2018-04-16 Marken James G. SVP Ops & Prod Dev Shares withheld for taxes −115 $60.21 $7K 69,333
2018-04-07 Marken James G. SVP Ops & Prod Dev Shares withheld for taxes −144 $57.06 $8K 69,448
2018-04-07 PRZYBYL ARTHUR President and CEO Shares withheld for taxes −2,014 $57.06 $115K 210,242
2018-04-07 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Shares withheld for taxes −391 $57.06 $22K 20,001
2018-04-06 Marken James G. SVP Ops & Prod Dev Grant or award +4,400 69,592
2018-04-06 Marken James G. SVP Ops & Prod Dev Grant or award · Stock Options +5,300 5,300
2018-04-06 CAREY STEPHEN P. Vice President and CFO Grant or award +8,000 14,118
2018-04-06 CAREY STEPHEN P. Vice President and CFO Grant or award · Stock Options +9,600 9,600
2018-04-06 PRZYBYL ARTHUR President and CEO Grant or award +29,100 212,256
2018-04-06 PRZYBYL ARTHUR President and CEO Grant or award · Stock Options +35,200 35,200
2018-04-06 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Grant or award +8,000 20,392
2018-04-06 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Grant or award · Stock Options +9,600 9,600
2018-03-31 Schrepfer Robert W SVP - New Bus Dev & Spec Sales Shares withheld for taxes −546 $58.22 $32K 12,392
2018-03-31 PRZYBYL ARTHUR President and CEO Shares withheld for taxes −2,550 $58.22 $148K 183,156
2018-03-31 CAREY STEPHEN P. Vice President and CFO Shares withheld for taxes −507 $58.22 $30K 6,118
2018-03-31 Marken James G. SVP Ops & Prod Dev Shares withheld for taxes −278 $58.22 $16K 65,192
2018-03-20 HOLUBOW FRED Director Exercise or conversion +2,000 14,811
2018-03-20 HOLUBOW FRED Director Exercise or conversion · Stock Options +2,000 1,333
2018-03-19 RAYNOR DANIEL Director Sale −5,313 $60.62 $322K 289,003

Page 32 of 41 · 804 trades